Skip to main content
VIKAS LIFECARE LIMITED logo

VIKAS LIFECARE LIMITED — Investor Relations & Filings

Ticker · VIKASLIFE ISIN · INE161L01027 LEI · 9845008856U9D9DABE98 BSE.NS Manufacturing
Open in API
Filings indexed 504 across all filing types
Latest filing 2025-04-08 Regulatory Filings
Country IN India
Listing BSE.NS VIKASLIFE

About VIKAS LIFECARE LIMITED

https://www.vikaslifecarelimited.com

Vikas Lifecare Limited is a diversified enterprise specializing in the manufacturing and trading of polymer and rubber compounds, specialty additives, and chemicals. The company produces high-performance polymer compounds utilized in sectors such as footwear, automotive, and infrastructure. Beyond its core chemical business, it has expanded into the Fast-Moving Consumer Goods (FMCG) and agro-products markets, focusing on the processing and distribution of premium food products. The company also provides infrastructure solutions, specifically in the domain of smart gas metering. A key aspect of its operations is the integration of recycled materials into its production cycles, reflecting a commitment to sustainable manufacturing. Its strategic focus involves vertical integration and portfolio diversification to address evolving industrial and consumer demands.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings
2025-04-08 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication from Vikas Lifecare Limited to the stock exchanges (NSE and BSE) regarding the closure of the trading window in compliance with SEBI regulations. It specifies the period during which insiders are prohibited from trading due to the upcoming announcement of financial results for the quarter and year ended March 31, 2025. There is no actual financial data, report, or detailed results included in the document. It is an announcement related to compliance and trading restrictions ahead of financial results disclosure. The document length is short (1981 characters), and it serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-03-29 English
General Updates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to the Listing Compliance Departments of the National Stock Exchange of India and BSE Limited. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content details the initiation of arbitration proceedings related to a consortium acquisition and financial claims, which is a significant legal and regulatory update. The document does not contain financial statements, earnings data, or detailed financial analysis, nor does it present a full report. Instead, it serves as a formal announcement of a material event (litigation/arbitration initiation) under regulatory requirements. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance disclosures that do not fit other specific categories.
2025-02-21 English
General Updates
Board/Management Information Classification · 95% confidence The document is an addendum to a previously submitted Board Meeting Outcome, specifically about the re-appointment of a Non-Executive, Independent Director. It includes details about the director's profile, term, and compliance disclosures. There is no financial data, earnings information, or report publication mentioned. The content focuses on management/board changes. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 4505 characters, which is consistent with a detailed announcement rather than a full report.
2025-02-18 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (NSE and BSE) regarding a regulatory action involving the company and a promoter being named in a Show Cause Notice by the Securities and Exchange Board of India (SEBI). It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30, which pertains to material events or information disclosures. The document details the nature of the regulatory action but does not contain financial statements, audit results, or detailed management discussion. It is a regulatory announcement about a legal proceeding or regulatory action rather than a full legal proceedings report or financial report. Given the nature of the content—disclosure of a regulatory notice and compliance with listing regulations—it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories. The document length is short (4165 characters), and it is not a report publication announcement or certification. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2025-02-17 English
General Updates
Earnings Release Classification · 95% confidence The document is a letter dated February 15, 2025, from Vikas Lifecare Limited addressed to the Listing Compliance Departments of the National Stock Exchange of India and BSE Limited. It announces the publication of the company's Un-Audited Financial Results for the quarter and nine months ended December 31, 2024. The document includes a newspaper advertisement of these financial results as published in newspapers, complying with regulatory disclosure requirements. The content is primarily an announcement of the publication of financial results, not the full financial report itself. The document length is about 15,000 characters, but the main content is the notification and advertisement of the results, not the detailed financial statements or management discussion. Therefore, this document is best classified as an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights, rather than a full Interim/Quarterly Report (IR) or Annual Report (10-K). 9M 2025
2025-02-15 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.